125 related articles for article (PubMed ID: 24434721)
1. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
[TBL] [Abstract][Full Text] [Related]
2. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
4. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population.
Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH
J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219
[TBL] [Abstract][Full Text] [Related]
6. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
Kwon KH; Lee YC; Chung JH; Eun YG
J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
[TBL] [Abstract][Full Text] [Related]
7. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
8. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
9. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
[TBL] [Abstract][Full Text] [Related]
10. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
[TBL] [Abstract][Full Text] [Related]
11. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
12. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
14. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
16. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
Zhu J; Qi P; Li Z
Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
[TBL] [Abstract][Full Text] [Related]
17. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
[TBL] [Abstract][Full Text] [Related]
18. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
[TBL] [Abstract][Full Text] [Related]
19. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Li H; Dai H; Li H; Li B; Shao Y
Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
